A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01455870 |
|
Recruitment Status :
Completed
First Posted : October 20, 2011
Last Update Posted : June 2, 2016
|
Sponsor:
Intarcia Therapeutics
Information provided by (Responsible Party):
Intarcia Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | July 2015 |
| Actual Study Completion Date : | July 2015 |
| Certification/Extension First Submitted : | May 13, 2016 |